ARTICLE | Clinical News
Exparel bupivacaine regulatory update
July 18, 2016 7:00 AM UTC
FDA posted a notice on its Adverse Event Reporting System (AERS) that the agency is evaluating the need for regulatory action for pain drug Exparel bupivacaine from Pacira related to local anesthetic ...